Hereditary haemochromatosis (HH) type 1 research hub

A research study to evaluate the effects of single doses of NNC0614-0001 in healthy adult volunteers, and participants with hereditary haemochromatosis type 1.

This study is testing a new medicine, NNC0614-0001, on healthy adults and people with a blood condition called hereditary haemochromatosis type 1. Researchers want to see how a single dose affects the body, as this is the first time it's being given to people.